Erratum for Kemeny et al., J Clin Oncol 19 (10) 2687-2695.
Erratum for Kirkwood et al., J Clin Oncol 19 (9) 2370-2380.
Erratum for Bast et al., J Clin Oncol 19 (6) 1865-1878.
Erratum for Kremer et al., J Clin Oncol 19 (1) 191-196.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ERRATA

In the January 1, 2001, issue of the Journal of Clinical Oncology, an article by Kremer et al, entitled "Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study" (J Clin Oncol 19:191-196, 2001), contained an error.

The legends of Fig 1 and Fig 2 on pages 193 and 195 were interchanged.

In the March 15, 2001, issue of the Journal of Clinical Oncology, an article by Pisters et al, entitled "Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors" (J Clin Oncol 19:1830-1838, 2001), contained an error.

The dose levels given in Fig 1-3 should be g/m², not mg/m².

In the March 15, 2001, issue, the ASCO Special Article by Bast et al, entitled "2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology" (J Clin Oncol 19:1865-1878, 2001), contained an error.

The first author’s name in reference 49 on page 1876 should be Starr A instead of Alexander S.

In the May 1, 2001, issue of the Journal of Clinical Oncology, the Rapid Publication by Kirkwood et al, entitled "High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801" (J Clin Oncol 19:2370-2380, 2001), contained an error.

In the Results section of the abstract, the survival hazard ratio (OS HR) for the eligible population should read 2.17, not 2.71.

In the May 15, 2001, issue of the Journal of Clinical Oncology, an article by Kemeny et al, entitled "Phase I Study of Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic Irinotecan for Unresectable Hepatic Metastases From Colorectal Cancer" (J Clin Oncol 19:2687-2695, 2001), contained an error.

Some of the partial responses in Table 5 were in the wrong column. The correct Table 5 is shown below.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?